Press Releases – Satellos

Satellos Bioscience to Participate at Biotech Showcase™ Virtual 2022

Satellos Bioscience to Participate at Biotech Showcase™ Virtual 2022 Toronto, January 6, 2022 - Satellos

Jessica Richmond2022-01-10T16:27:13+00:00January 10th, 2022|2022, Press Releases|

SATELLOS BIOSCIENCE INC. ANNOUNCES SCIENTIFIC RESEARCH AGREEMENT WITH UNIVERSITÉ DE SHERBROOKE TO STUDY RARE MUSCULAR

Jessica Richmond2021-12-16T12:13:11+00:00December 16th, 2021|2021, Press Releases|

SATELLOS BIOSCIENCE ANNOUNCES NEW BOARD APPOINTMENTS Satellos welcomes new board members to strengthen its pharmaceutical

Jessica Richmond2021-12-06T13:47:30+00:00December 6th, 2021|2021, Press Releases|

SATELLOS BIOSCIENCE REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Satellos positioned to pursue

Jessica Richmond2021-12-02T14:42:01+00:00November 29th, 2021|2021, Press Releases|

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO,

ico_admin2021-12-02T16:35:40+00:00October 26th, 2021|2021, Press Releases|

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES Toronto,

ico_admin2021-12-02T16:36:02+00:00September 17th, 2021|2021, Press Releases|

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO,

ico_admin2021-12-02T16:36:17+00:00September 13th, 2021|2021, Press Releases|

Toronto, Ontario -- (August 30, 2021) Satellos Therapeutics Inc. (TSXV: MSCL) ("Satellos"), formerly iCo Therapeutics

ico_admin2021-12-02T16:37:02+00:00August 30th, 2021|2021, Press Releases|

SATELLOS BIOSCIENCE Announces High Resolution Crystal Structure of Duchenne Drug Target TORONTO, ONTARIO –August 26,

ico_admin2021-12-02T16:37:23+00:00August 26th, 2021|2021, Press Releases|

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO,

ico_admin2021-12-02T16:36:36+00:00August 25th, 2021|2021, Press Releases|